Altered ionic permeability in skeletal muscle from horses with hyperkalemic periodic paralysis.

The research article investigates the alterations in ionic permeability in skeletal muscle of horses affected by hyperkalemic periodic paralysis (HPP), a muscle disorder also found in humans. The characteristics of this condition are explored through muscle biopsies from normal and affected horses, highlighting a potential genetic defect shared between the species.

Introduction and Objectives

• The study focuses on a disorder observed in Quarter horses that has striking resemblances with the muscle disease known as hyperkalemic periodic paralysis (HPP) in humans.
• The key purpose was to examine whether alterations in membrane permeability or Na(+)-K+ pump activity, considered as possible causes of the muscle depolarization and inexcitability defining this condition in humans, could be associated with the pathology observed in horses.

Research Methodology

• Biopsies of the external intercostal muscle were conducted both from normal and HPP affected horses.
• Through these biopsies, the researchers tried to establish whether the abnormalities in either permeability and/or pump activity formed the basis of the condition in horses.

Findings and Implications

• The muscle of horses affected by HPP is found to be approximately 16 mV more depolarized than standard muscle during rest, indicating a significant difference in electrical potential.
• Furthermore, it was noted that HPP horses exhibited a less responsive muscle membrane potential to changes in external K+.
• Upon calculating the relative membrane permeabilities of Na+ and K+ (PNa/PK), the researchers discovered a significantly larger ratio in the muscles affected by HPP.
• This increase is attributed to a probable enhancement in PNa as opposed to a reduction in PK – an inference bolstered by the fact that application of 10(-6) M tetrodotoxin led to a roughly 14-mV membrane hyperpolarization in HPP fibers, but no change in unaffected fibers.
• These findings, when combined with the clinical similarities observed between HPP in horses and humans, indicate a potential shared genetic defect in both species, opening doors for further research and potential therapeutic approaches for treating HPP in both horses and humans.